PITTSBURGH, Jan. 21 Precision Therapeutics, Inc. today announced that CEO Sean McDonald provided a company presentation at the J.P. Morgan 28th Annual Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California, on Thursday, January 14, 2010. The presentation included a discussion of the company's marketed products, its strategy for growth, and other matters relating to its business.
Advertisement
Precision Therapeutics, headquartered in Pittsburgh, Pennsylvania, is a life science company and leader in the development of innovative technology that delivers personalized diagnostics to physicians with the goal of supporting and optimizing difficult cancer therapy decisions.
Advertisement
Precision's ChemoFx®, a proprietary drug response marker, measures an individual patient's tumor response to various chemotherapeutic and biological agents prior to treating the patient. ChemoFx® can complement the physician's experience and provide valuable patient-specific information, as there is typically not a uniform response to standard cancer treatment or no clear choice for the next regimen.
For more information:
http://www.precisiontherapeutics.com
http://www.chemofx.com
SOURCE Precision Therapeutics, Inc.
